Clinical Trials Directory

Trials / Completed

CompletedNCT05458635

Predictors of Pulmonary Hypertension in Patients With Hypersensitivity Pneumonitis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
29 Years – 55 Years
Healthy volunteers
Not accepted

Summary

Hypersensitivity pneumonitis (HP) is a complex immune mediated disorders caused by repeated inhalation of and sensitization to wide range of antigens including organic particles and chemical compounds, leading to exaggerated immuneresponse. Hypersenstivity pneumonitis is a common form of diffuse parenchymal lung diseases in Egypt .Pulmonary hypertension has been found as a complication of a number of diseases affecting the lung interstitium, including hypersensitivity pneumonitis, with subsequent affection of the life expectancy Rationale of the study: to find predictors for the development of pulmonary hypertension in patients with hypersensitivity pneumonitis

Detailed description

Cross sectional study included 60 patients with established diagnosis of HP , work up includes history of exposure, clinical examination, HRCT chest, ABGs,6MWD, desaturation degree , spirometry, echocardiography and right heart catheter in patients with high echo probability of PH.

Conditions

Interventions

TypeNameDescription
PROCEDURERight heart catheterRight heart catheterization was performed for 4 cases with high probability of pulmonary hypertension using multi-lumen swan ganz catheter.

Timeline

Start date
2019-08-01
Primary completion
2020-10-31
Completion
2021-03-15
First posted
2022-07-14
Last updated
2022-07-14

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05458635. Inclusion in this directory is not an endorsement.